Microsoft word - fatty liver1.doc

Fatty Liver disease
What is Fatty Liver disease?
Nonalcoholic steatohepatitis (NASH) is a condition characterised by inflammation and the accumulation of fat and fibrous
tissue in the liver. Although similar findings can be seen in patients who abuse alcohol, NASH occurs in people who do
not drink. The exact cause of NASH is unknown. However, it is seen commonly in people with certain medical conditions
such as diabetes and obesity. It is diagnosed in about 10% of people who have a liver biopsy. Most affected people are
between the ages of 40 and 60 years, although the condition can also occur in children over the age of 10 years. NASH is
seen more often in women than men. Fatty liver is typically a chronic condition. Most people with this condition will not
develop serious liver problems. On the other hand, in others the condition can lead to progressive scarring and cirrhosis.
Cirrhosis is the term used to describe a diseased liver that has been severely scarred. Unfortunately, it is difficult to
predict the natural course of Fatty liver in individual patients.
Why have I developed Fatty Liver Disease?
��Obesity —70% of people with Fatty liver are upto 40% overweight.
��Diabetes—75% of people with Fatty liver have diabetes mellitus.
��Hyperlipidemia — Upto 80% of people have high triglyceride and/or cholesterol levels
��Insulin resistance —Refers to a state in which the body does not respond adequately to insulin
What drugs should I avoid?
Several drugs used to treat medical conditions have been linked to fatty liver, including Amiodarone, Tamoxifen, Ca+
channel blockers, tetracyclines, perhexilene, glucocorticoids, synthetic estrogens, Valproate, chloroquine, and pesticides
What symptoms can I expect?
Most people with Fatty liver have no symptoms. Rarely, Fatty liver is diagnosed after patients consult their doctor because
of fatigue, a general feeling of being unwell, and vague discomfort in the upper right abdomen.
How is Fatty Liver diagnosed?
Fatty liver is most often discovered during routine laboratory testing. Additional tests help confirm the presence of Fatty
liver and rule out other types of liver disease. An ultrasound or CT scan is also a common method of detection. However,
these scans often fail to detect accumulation of fibrous tissue or inflammation and cannot differentiate Fatty liver from
other causes of liver disease that can have a similar appearance.
What do my Liver function tests reveal?
Liver function tests determine blood levels of substances produced by the liver. They can be helpful for diagnosing Fatty
liver and for differentiating it from alcoholic hepatitis. Levels of two liver enzymes (aspartate aminotransferase [AST] and
alanine aminotransferase [ALT]) are elevated in 90% of people with Fatty liver; ALT/AST ratio is usually >1
Is a Liver biopsy needed?
Although other tests may suggest that a person has Fatty liver, a liver biopsy is the only test that can definitely confirm or
rule out the presence of Fatty liver. During a liver biopsy, small samples of liver tissue are collected and sent to the
laboratory for microscopic examination and biochemical testing. A liver biopsy is also helpful for determining the severity
of Fatty liver, and in some cases, it may also provide clues about the future course of the condition.
What treatment I available? At this time, there are no cures for Fatty liver. The main goal of treatment is to:
�� Treat high cholesterol, and diabetes,
�� Avoid alcohol and drugs that may effect the liver.
�� Weight reduction (approximately 10%) Xenical and weight loss drugs may help
�� Diet (Low carbohydrate, High Protein diet) avoiding high glycaemic (glucose) foods
�� Omega 3 fatty acids 1000mg daily (Fish oil capsules) have been shown to improve insulin resistance
�� Vitamin E 1000 units daily may improve Liver function tests
�� Vitamin C 1000 mg daily
�� Silymarin (Milk Thistle) May be beneficial although cannot be routinely recommended.
�� Alpha Lipoic acid 600mg daily can also help
�� Metformin at 500mg bd if signs of elevated glucose are present

What are the longterm risks?
The good news is that in most people, fatty liver appears to be a stable medical condition. The results of one study
showed that people with fatty liver live just as long as people without this condition. However NASH can progress in some
people due to progressive fibrosis and eventual cirrhosis. This is seen in about 20% of people after 20 years.
DR. JOHN GOY DR. DAVID RUBINSTEIN DR. WAYNE FRIEDMAN DR. MALCOLM BARNES

Source: http://www.digestivehealth.com.au/pdf/patient-info-sheets/Fatty-Liver1.pdf

hggm.es

A European perspective on intravascular catheter-related infections: reporton the microbiology workload, aetiology and antimicrobial susceptibility(ESGNI-005 Study)E. Bouza1, R. San Juan1, P. Mun˜oz1, J. Pascau2, A. Voss3 and M. Desco2 on behalf of the CooperativeGroup of the European Study Group on Nosocomial Infections (ESGNI)1Clinical Microbiology and Infectious Diseases and 2Experimental Med

ecvhornets-hc.co.uk

LUCOZADE SPORT SCIENCE: CAFFEINE USE IN SPORT Caffeine can improve performance in both short and long term endurance events as well as short term high intensity intermittent exercise. Caffeine can improve many of the cognitive (mental processing) attributes important to sport such as alertness, concentration, reaction time and focus. The mechanism(s) behind the performance be

Copyright © 2018 Medical Abstracts